General Information of the Compound
| Compound ID |
CP0503486
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(1S)-3-[4-[5-[(dimethylamino)methyl]-1,3,4-oxadiazol-2-yl]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H37N5O2
|
||||||||||||||||||
| Molecular Weight |
439.604
|
||||||||||||||||||
| Canonical SMILES |
CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(CC1)c1nnc(CN(C)C)o1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H37N5O2/c1-18(16-22(19-8-5-4-6-9-19)26-24(31)20-10-7-11-20)30-14-12-21(13-15-30)25-28-27-23(32-25)17-29(2)3/h4-6,8-9,18,20-22H,7,10-17H2,1-3H3,(H,26,31)/t18?,22-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DIAMDXFHMNROML-YSYXNDDBSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00903, C-C chemokine receptor type 5
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2